Minutes - Medication WG 2023-04-18

From Health Level 7 Belgium Wiki
Revision as of 09:57, 18 April 2023 by KarlienErauw (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Attendees
  • Annemieke Vergauwe
  • Bart Decuypere
  • Bart Rondou
  • Hans De Keersmaeker
  • José Costa Teixeira
  • Karlien Erauw
  • Lodewijk Sioen
  • Pablo Christiaens
  • Stephane Bouillon
  • Thomas Van Langendonck
Excused/Not present
  • Anne Nerenhausen
  • Bruno Casneuf
  • Dieter Sauvillers
  • Hanne Vuegen
  • Jan Lenie
  • Jean-Michel Polfliet
  • Jens Penny
  • Katrien Thorré
  • Lars Vanreppelen
  • Richard Francken
  • Marc Buckens
  • Nick Hermans
  • Nils Devos
  • Tom De Backer
  • Tom Henkens
  • Walter Bollaert
  • Will van Norel
Agenda
  • Mapping from the current kmehr medication scheme into FHIR
  • Mapping of posology
Minutes
  • VIDIS project : functional equivalent of the kmehr MS
  • some documentation on the kmehr MS is missing
  • cookbook's data elements have being analysed and have been mapped to FHIR resources
  • different valuesets came up: route of administration, adm unit, periodicity
  • while migrating the goal is to clean up the valuesets
  • update of valuesets : no update from Jens
  • plan is to land with a final draft of the FHIR MS in the upcoming months
  • medication lines can be part of a treatment
  • one treatment can have multiple lines, is the treatment a parent or is it a group(er), can a line then have 2 parents (hierarchy doesn't seem a good idea)
  • this and logical model and profile are still being discussed and under development
  • there will be a shift from treatment to prescription while currently the HCP starts with a prescription
  • this is happening in Swiss (treatment=plan there)
  • need for FHIR profiling:
  • medication dispense
  • medication treatment & medication line incl links between them
  • medication prescription: will recip-e move to FHIR ?
  • it would be ideal to have all in FHIR as otherwise you would have the posology in kmehr and valuesest in kmehr and in FHIR
  • what are the interaction and dependencies b/w the prescription and the MS
  • We are looking to bring together IHE Pharmacy and discussion with Swiss, most probably beginning of July
  • assessment what is needed and not needed anymore for the VIDIS project (MS in FHIR)
  • currently there are 2 transactions : medication line and treatment suspension line
  • the treatment suspension line seems not needed anymore for VIDIS (MS in FHIR)
  • valueset mapping: some statistics have been made
  • where do we need unique identifiers: on medication line and on entire medication scheme
  • where do we need authors: on medication line and on entire medication scheme
  • a hospital, institution or pharmacy cannot be an author, should always be an individual ; the organisation could be added additionnally
  • more feedback is needed
  • catalog of used valuesets should be made (f.e. different versions of administration units are being used by reip-ce, SAMv2 ...): ideally as part of
  • Action items:
  • consolidate current IG, remove items that are not needed
  • work on valuesets

Next meeting 9 May at 11AM